US5308460A - Rapid synthesis and analysis of carbohydrates - Google Patents
Rapid synthesis and analysis of carbohydrates Download PDFInfo
- Publication number
- US5308460A US5308460A US07/968,980 US96898092A US5308460A US 5308460 A US5308460 A US 5308460A US 96898092 A US96898092 A US 96898092A US 5308460 A US5308460 A US 5308460A
- Authority
- US
- United States
- Prior art keywords
- carbohydrate
- reaction
- gel
- substrate
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 201
- 235000014633 carbohydrates Nutrition 0.000 title claims abstract description 197
- 238000004458 analytical method Methods 0.000 title claims abstract description 35
- 238000003786 synthesis reaction Methods 0.000 title abstract description 91
- 230000015572 biosynthetic process Effects 0.000 title description 73
- 102000004190 Enzymes Human genes 0.000 claims abstract description 193
- 108090000790 Enzymes Proteins 0.000 claims abstract description 193
- 238000006243 chemical reaction Methods 0.000 claims abstract description 175
- 239000011159 matrix material Substances 0.000 claims abstract description 148
- 239000000758 substrate Substances 0.000 claims abstract description 145
- 238000000034 method Methods 0.000 claims abstract description 94
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 72
- 238000001962 electrophoresis Methods 0.000 claims abstract description 63
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 12
- 238000003556 assay Methods 0.000 claims description 49
- 239000011541 reaction mixture Substances 0.000 claims description 45
- 238000002372 labelling Methods 0.000 claims description 17
- 238000012986 modification Methods 0.000 claims description 8
- 230000004048 modification Effects 0.000 claims description 8
- 230000000051 modifying effect Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000001308 synthesis method Methods 0.000 abstract description 6
- 229940088598 enzyme Drugs 0.000 description 163
- 239000000499 gel Substances 0.000 description 160
- 239000000047 product Substances 0.000 description 26
- 229920001542 oligosaccharide Polymers 0.000 description 19
- 150000002482 oligosaccharides Chemical class 0.000 description 19
- 238000001514 detection method Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 230000002255 enzymatic effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 108060003306 Galactosyltransferase Proteins 0.000 description 12
- 102000030902 Galactosyltransferase Human genes 0.000 description 12
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 12
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 11
- QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 description 10
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000001952 enzyme assay Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229920002401 polyacrylamide Polymers 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- 102000051366 Glycosyltransferases Human genes 0.000 description 5
- 108700023372 Glycosyltransferases Proteins 0.000 description 5
- 102000004407 Lactalbumin Human genes 0.000 description 5
- 108090000942 Lactalbumin Proteins 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 235000020256 human milk Nutrition 0.000 description 5
- 210000004251 human milk Anatomy 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- UBDHSURDYAETAL-UHFFFAOYSA-N 8-aminonaphthalene-1,3,6-trisulfonic acid Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(N)=CC(S(O)(=O)=O)=CC2=C1 UBDHSURDYAETAL-UHFFFAOYSA-N 0.000 description 4
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 4
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 4
- 230000003100 immobilizing effect Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- -1 nucleoside mono- Chemical class 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000021241 α-lactalbumin Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000013009 Pyruvate Kinase Human genes 0.000 description 3
- 108020005115 Pyruvate Kinase Proteins 0.000 description 3
- XCCTYIAWTASOJW-UHFFFAOYSA-N UDP-Glc Natural products OC1C(O)C(COP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-UHFFFAOYSA-N 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000001444 catalytic combustion detection Methods 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- CMOLPZZVECHXKN-UHFFFAOYSA-N 7-aminonaphthalene-1,3-disulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=CC(N)=CC=C21 CMOLPZZVECHXKN-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102100039847 Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 101000887519 Homo sapiens Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 Proteins 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 2
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- LFTYTUAZOPRMMI-NESSUJCYSA-N UDP-N-acetyl-alpha-D-galactosamine Chemical compound O1[C@H](CO)[C@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-NESSUJCYSA-N 0.000 description 2
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- OGGXGZAMXPVRFZ-UHFFFAOYSA-N dimethylarsinic acid Chemical compound C[As](C)(O)=O OGGXGZAMXPVRFZ-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- NRZRRZAVMCAKEP-UHFFFAOYSA-N naphthionic acid Chemical compound C1=CC=C2C(N)=CC=C(S(O)(=O)=O)C2=C1 NRZRRZAVMCAKEP-UHFFFAOYSA-N 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 2
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- PIGCSKVALLVWKU-UHFFFAOYSA-N 2-Aminoacridone Chemical compound C1=CC=C2C(=O)C3=CC(N)=CC=C3NC2=C1 PIGCSKVALLVWKU-UHFFFAOYSA-N 0.000 description 1
- KFTHUBZIEMOORC-UHFFFAOYSA-N 2-methylbut-2-enamide Chemical compound CC=C(C)C(N)=O KFTHUBZIEMOORC-UHFFFAOYSA-N 0.000 description 1
- WXKWWBWCMOQLOP-UHFFFAOYSA-N 8-aminonaphthalene-1,3-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(N)=CC=CC2=C1 WXKWWBWCMOQLOP-UHFFFAOYSA-N 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000007978 cacodylate buffer Substances 0.000 description 1
- 229950004243 cacodylic acid Drugs 0.000 description 1
- 238000005515 capillary zone electrophoresis Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 125000001905 inorganic group Chemical group 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000011089 mechanical engineering Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- PJTTXANTBQDXME-UGDNZRGBSA-N sucrose 6(F)-phosphate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 PJTTXANTBQDXME-UGDNZRGBSA-N 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
Definitions
- carbohydrate substrates are preferably labelled with a fluorophore before the substrate is added to the reaction matrix gel, i.e., pre-labelling.
- pre-labelling of a carbohydrate substrate may alter the activity of some carbohydrate-modifying enzymes.
- it may be necessary to pre-label some substrate molecules with an additional sugar or a spacer molecule attached to a point sufficiently distant from the point (or points) of substrate-enzyme interaction so as to avoid altering the interaction between enzyme and substrate.
- Suitable spacer molecules and methods of their chemical attachment to an appropriate sugar are known to those skilled in the art. The requirement of an additional sugar(s) or spacer molecule in pre-labelling may be obviated when the labelling is done following the enzyme-mediated synthesis or modification.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/968,980 US5308460A (en) | 1992-10-30 | 1992-10-30 | Rapid synthesis and analysis of carbohydrates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/968,980 US5308460A (en) | 1992-10-30 | 1992-10-30 | Rapid synthesis and analysis of carbohydrates |
Publications (1)
Publication Number | Publication Date |
---|---|
US5308460A true US5308460A (en) | 1994-05-03 |
Family
ID=25515018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/968,980 Expired - Lifetime US5308460A (en) | 1992-10-30 | 1992-10-30 | Rapid synthesis and analysis of carbohydrates |
Country Status (1)
Country | Link |
---|---|
US (1) | US5308460A (en) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672881A (en) * | 1994-09-14 | 1997-09-30 | Glyko, Inc. | Charge-coupled device imaging apparatus |
US6127153A (en) * | 1995-06-07 | 2000-10-03 | Neose Technologies, Inc. | Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase |
US6190522B1 (en) | 1998-04-24 | 2001-02-20 | Board Of Regents, The University Of Texas System | Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis |
US6331418B1 (en) * | 1990-04-16 | 2001-12-18 | Neose Technologies, Inc. | Saccharide compositions, methods and apparatus for their synthesis |
WO2002012547A1 (en) * | 2000-08-08 | 2002-02-14 | Aclara Biosciences, Inc. | Multiplexed enzymatic assays |
US6518051B1 (en) * | 1991-04-11 | 2003-02-11 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US6534321B1 (en) * | 1996-07-10 | 2003-03-18 | Oxford Glycosciences (Uk) Ltd. | Assaying and storing labelled analytes |
US20030170828A1 (en) * | 2000-08-22 | 2003-09-11 | Wei Zou | Synthesis of complex carbohydrates |
US20030232383A1 (en) * | 2001-11-02 | 2003-12-18 | Sylvia Daunert | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
US6709596B1 (en) * | 2002-04-04 | 2004-03-23 | University Of New Hampshire | Device, method and system for reversibly trapping and isolating carbohydrates |
US20040058448A1 (en) * | 1999-05-18 | 2004-03-25 | Apicella Michael A. | Production of complex carbohydrates |
KR100426612B1 (en) * | 1999-06-10 | 2004-04-08 | 한국과학기술연구원 | Facile determination of immobilized carbohydrate |
US6780980B1 (en) * | 1999-06-30 | 2004-08-24 | Centre Suisse D'electronique Et De Microtechnique S.A. | Process for the modification of surface |
US20050003988A1 (en) * | 2003-06-27 | 2005-01-06 | The Procter & Gamble Company | Enzyme bleach lipophilic fluid cleaning compositions |
US20060019302A1 (en) * | 2004-07-23 | 2006-01-26 | Charles Lemme | Method and apparatus for applying fluids to a biological sample |
US20080187955A1 (en) * | 2001-10-10 | 2008-08-07 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US20080253992A1 (en) * | 2006-10-03 | 2008-10-16 | Neose Technologies, Inc. | Methods for the purification of polypeptide conjugates |
US20080280818A1 (en) * | 2006-07-21 | 2008-11-13 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
US20090124544A1 (en) * | 2005-04-08 | 2009-05-14 | Neose Technologies ,Inc. A Delaware Corporation | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US20090305967A1 (en) * | 2005-08-19 | 2009-12-10 | Novo Nordisk A/S | Glycopegylated factor vii and factor viia |
US20100330645A1 (en) * | 2005-08-19 | 2010-12-30 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8501434B2 (en) | 2010-10-06 | 2013-08-06 | Biocare, LLC | Method for processing non-liquid biological samples with dynamic application of a processing liquid |
US8716239B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
US9050304B2 (en) | 2007-04-03 | 2015-06-09 | Ratiopharm Gmbh | Methods of treatment using glycopegylated G-CSF |
US9150848B2 (en) | 2008-02-27 | 2015-10-06 | Novo Nordisk A/S | Conjugated factor VIII molecules |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
US9945763B1 (en) | 2011-02-18 | 2018-04-17 | Biocare Medical, Llc | Methods and systems for immunohistochemistry heat retrieval of biological samples |
US10908164B2 (en) | 2011-08-12 | 2021-02-02 | Life Technologies Corporation | Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5100778A (en) * | 1989-10-03 | 1992-03-31 | Monsanto Company | Oligosaccharide sequencing |
WO1992011531A1 (en) * | 1990-12-22 | 1992-07-09 | Glyko, Inc. | Analysis of carbohydrates using 2-aminoacridone |
US5205917A (en) * | 1991-05-07 | 1993-04-27 | Glyko, Inc. | Fluorophore assisted carbohydrate electrophoresis diagnosis |
-
1992
- 1992-10-30 US US07/968,980 patent/US5308460A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5100778A (en) * | 1989-10-03 | 1992-03-31 | Monsanto Company | Oligosaccharide sequencing |
WO1992011531A1 (en) * | 1990-12-22 | 1992-07-09 | Glyko, Inc. | Analysis of carbohydrates using 2-aminoacridone |
US5205917A (en) * | 1991-05-07 | 1993-04-27 | Glyko, Inc. | Fluorophore assisted carbohydrate electrophoresis diagnosis |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331418B1 (en) * | 1990-04-16 | 2001-12-18 | Neose Technologies, Inc. | Saccharide compositions, methods and apparatus for their synthesis |
US6518051B1 (en) * | 1991-04-11 | 2003-02-11 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US5672881A (en) * | 1994-09-14 | 1997-09-30 | Glyko, Inc. | Charge-coupled device imaging apparatus |
US6127153A (en) * | 1995-06-07 | 2000-10-03 | Neose Technologies, Inc. | Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase |
US6379933B1 (en) | 1995-06-07 | 2002-04-30 | Neose Technologies, Inc. | Method of transferring at least two saccharide units with a polyglycosyltransferase |
US6534321B1 (en) * | 1996-07-10 | 2003-03-18 | Oxford Glycosciences (Uk) Ltd. | Assaying and storing labelled analytes |
US6190522B1 (en) | 1998-04-24 | 2001-02-20 | Board Of Regents, The University Of Texas System | Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis |
US20040058448A1 (en) * | 1999-05-18 | 2004-03-25 | Apicella Michael A. | Production of complex carbohydrates |
US6743607B2 (en) | 1999-05-18 | 2004-06-01 | The Regents Of The University Of California | Production of complex carbohydrates |
KR100426612B1 (en) * | 1999-06-10 | 2004-04-08 | 한국과학기술연구원 | Facile determination of immobilized carbohydrate |
US6780980B1 (en) * | 1999-06-30 | 2004-08-24 | Centre Suisse D'electronique Et De Microtechnique S.A. | Process for the modification of surface |
US6630296B2 (en) | 2000-08-08 | 2003-10-07 | Aclara Biosciences, Inc. | Multiplexed enzymatic assays |
WO2002012547A1 (en) * | 2000-08-08 | 2002-02-14 | Aclara Biosciences, Inc. | Multiplexed enzymatic assays |
US6846645B2 (en) | 2000-08-08 | 2005-01-25 | Aclara Biosciences, Inc. | Multiplexed enzymatic assays |
AU2001279222B2 (en) * | 2000-08-08 | 2006-03-02 | Monogram Biosciences, Inc. | Multiplexed enzymatic assays |
US20030170828A1 (en) * | 2000-08-22 | 2003-09-11 | Wei Zou | Synthesis of complex carbohydrates |
US8716239B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF |
US8716240B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US20080187955A1 (en) * | 2001-10-10 | 2008-08-07 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US20030232383A1 (en) * | 2001-11-02 | 2003-12-18 | Sylvia Daunert | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
US6998041B2 (en) | 2002-04-04 | 2006-02-14 | University Of New Hampshire | Device and system for reversibly trapping and isolating carbohydrates |
US20050000896A1 (en) * | 2002-04-04 | 2005-01-06 | Reinhold Vernon N. | Device and system for reversibly trapping and isolating carbohydrates |
US6709596B1 (en) * | 2002-04-04 | 2004-03-23 | University Of New Hampshire | Device, method and system for reversibly trapping and isolating carbohydrates |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US20050003988A1 (en) * | 2003-06-27 | 2005-01-06 | The Procter & Gamble Company | Enzyme bleach lipophilic fluid cleaning compositions |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US20060019302A1 (en) * | 2004-07-23 | 2006-01-26 | Charles Lemme | Method and apparatus for applying fluids to a biological sample |
AU2005267018B2 (en) * | 2004-07-23 | 2008-10-23 | Ventana Medical Systems, Inc. | Method and apparatus for applying fluids to a biological sample |
US7820381B2 (en) * | 2004-07-23 | 2010-10-26 | Ventana Medical Systems, Inc. | Method and apparatus for applying fluids to a biological sample |
US10874714B2 (en) | 2004-10-29 | 2020-12-29 | 89Bio Ltd. | Method of treating fibroblast growth factor 21 (FGF-21) deficiency |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
US20090124544A1 (en) * | 2005-04-08 | 2009-05-14 | Neose Technologies ,Inc. A Delaware Corporation | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US8911967B2 (en) | 2005-08-19 | 2014-12-16 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US20090305967A1 (en) * | 2005-08-19 | 2009-12-10 | Novo Nordisk A/S | Glycopegylated factor vii and factor viia |
US20100330645A1 (en) * | 2005-08-19 | 2010-12-30 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
US20080280818A1 (en) * | 2006-07-21 | 2008-11-13 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
US20080253992A1 (en) * | 2006-10-03 | 2008-10-16 | Neose Technologies, Inc. | Methods for the purification of polypeptide conjugates |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US9050304B2 (en) | 2007-04-03 | 2015-06-09 | Ratiopharm Gmbh | Methods of treatment using glycopegylated G-CSF |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
US9150848B2 (en) | 2008-02-27 | 2015-10-06 | Novo Nordisk A/S | Conjugated factor VIII molecules |
US9442049B2 (en) | 2010-10-06 | 2016-09-13 | Biocare Medical, Llc | Efficient processing systems and methods for biological samples |
US8501434B2 (en) | 2010-10-06 | 2013-08-06 | Biocare, LLC | Method for processing non-liquid biological samples with dynamic application of a processing liquid |
US9945763B1 (en) | 2011-02-18 | 2018-04-17 | Biocare Medical, Llc | Methods and systems for immunohistochemistry heat retrieval of biological samples |
US10908164B2 (en) | 2011-08-12 | 2021-02-02 | Life Technologies Corporation | Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5308460A (en) | Rapid synthesis and analysis of carbohydrates | |
EP0525821B1 (en) | Methods and structures employing non-radioactive chemically-labeled polynucleotide probes | |
US6287774B1 (en) | Assay methods and system | |
US6472141B2 (en) | Kinase assays using polycations | |
US5856082A (en) | Devices and methods for characterizing proteins and peptides | |
Fan et al. | Advances in-capillary electrophoretic enzyme assays | |
Glatz | Determination of enzymatic activity by capillary electrophoresis | |
Bao et al. | Determination of minute enzymatic activities by means of capillary electrophoretic techniques | |
Huang et al. | Advances in capillary electrophoretically mediated microanalysis for on‐line enzymatic and derivatization reactions | |
Van Dyck et al. | Advances in capillary electrophoretically mediated microanalysis | |
US6048707A (en) | Fluorophore assisted derivatization analysis of carbohydrates | |
US4900423A (en) | Enzyme sensor using immobilized glucokinase | |
JPS6347649A (en) | Enzyme sensor for measuring glutamic acid | |
US4263406A (en) | Apparatus for continuously referenced analysis of reactive components in solution | |
Sakai-Kato et al. | On-line drug–metabolism system using microsomes encapsulated in a capillary by the sol–gel method and integrated into capillary electrophoresis | |
US5258295A (en) | Fluorophore-assisted cloning analysis | |
Gebauer et al. | Ion selective electrode estimation of avidin and biotin using a lysozyme label | |
Le et al. | Study of the enzymatic transformation of fluorescently labeled oligosaccharides in human epidermoid cells using capillary electrophoresis with laser-induced fluorescence detection | |
Zhang et al. | Recent developments and applications of EMMA in enzymatic and derivatization reactions | |
Wakarchuk et al. | Capillary electrophoresis as an assay method for monitoring glycosyltransferase activity | |
US5109126A (en) | 5'[2'(3')-O-(2,4,6-trinitrophenyl) pyprimidine nucleoside]diphosphate 1-glycosides | |
US5173407A (en) | Method for measuring glycosyltransferase | |
JP2005502030A (en) | Protein analysis system and method | |
Hubl et al. | Thin-layer chromatography and polyacrylamide gel electrophoresis-based assays for sialyltransferases using tetramethylrhodamine-labeled acceptors | |
Chen et al. | Assay of enzymes by capillary electrophoresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GLYKO, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:MAZID, M. ABDUL;KLOCK, JOHN C.;REEL/FRAME:006433/0313 Effective date: 19930127 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: PROZYME, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GLYKO, INC.;REEL/FRAME:020540/0172 Effective date: 20080122 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |